FS-108,an Hsp90 inhibitor,impairs survival and motility of oncogene addicted cancer cells
Ping Fangfang3; Wang Yueqin2; Zhang Minmin2; Shi Feng1; Chen Danqi1; Ding Jian2
刊名Chinese Pharmacological Bulletin
2016
卷号32期号:10页码:1357-1363
关键词Hsp90 caspase-3 Hsp90 EBC-1 and A375 cells G_2/M arrest apoptosis Caspase-3 migration
ISSN号1001-1978
其他题名Hsp90抑制剂FS-108抑制癌基因依赖肿瘤细胞增殖及运动的机制研究
文献子类Review
英文摘要Aim To investigate the anti-tumor effects of FS-108 an Hsp90 inhibitor, on oncogene addicted EBC-1 and A375 cells. Methods SRB assay was performed to investigate cell proliferation. Immunoblot was conducted to investigate the specific proteins. FACS was conducted to test cell cycle distribution and apoptosis. Transwell assay was conducted to investigate cell motility. Results FS-108 significantly suppressed cell proliferation of EBC-1 and A375 cancer cells with IC_(50) at 25.53 nmol ? L~(-1) and 30.02 nmol ? L~(-1) respectively. FS-108 treatment triggered the degradation of key client proteins such as c-Met and B-Raf and thereby reduced their downstream AKT and ERK signaling pathways. The FACS analysis results demonstrated that FS-108 treatment induced G_2/M phase arrest and apoptosis significantly. Furthermore, FS-108 inhibited the migration of EBC-1 and A375 cells. Conclusion As a potent Hsp90 inhibitor, FS-108 can inhibit oncogene addicted cancer cells proliferation through induction of G_2/M phase arrest and apoptosis.
资助项目国家自然科学基金资助项目[00000000]
WOS研究方向General & Internal Medicine ; Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:5820180
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/269233]  
专题药理学第一研究室
通讯作者Ding Jian
作者单位1.Synthetic Organic and Medicinal Chemistry Laboratory, Shanghai Institute of Material Medicine, University of Chinese Academy of Sciences, Shanghai 201203, China.
2.State Key Laboratory of Drug Research, Shanghai Institute of Material Medicine, University of Chinese Academy of Sciences, Shanghai 201203, China.;
3.College of Life Science, Shanghai University, State Key Laboratory of Drug Research, Shanghai 200444, China.;
推荐引用方式
GB/T 7714
Ping Fangfang,Wang Yueqin,Zhang Minmin,et al. FS-108,an Hsp90 inhibitor,impairs survival and motility of oncogene addicted cancer cells[J]. Chinese Pharmacological Bulletin,2016,32(10):1357-1363.
APA Ping Fangfang,Wang Yueqin,Zhang Minmin,Shi Feng,Chen Danqi,&Ding Jian.(2016).FS-108,an Hsp90 inhibitor,impairs survival and motility of oncogene addicted cancer cells.Chinese Pharmacological Bulletin,32(10),1357-1363.
MLA Ping Fangfang,et al."FS-108,an Hsp90 inhibitor,impairs survival and motility of oncogene addicted cancer cells".Chinese Pharmacological Bulletin 32.10(2016):1357-1363.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace